These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31104028)

  • 1. Association between Sleep Disturbances and Medial Temporal Lobe Volume in Older Adults with Mild Cognitive Impairment Free of Lifetime History of Depression.
    Yuen K; Rashidi-Ranjbar N; Verhoeff NPLG; Kumar S; Gallagher D; Flint AJ; Herrmann N; Pollock BG; Mulsant BH; Rajji TK; Voineskos AN; Fischer CE; Mah L;
    J Alzheimers Dis; 2019; 69(2):413-421. PubMed ID: 31104028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
    Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
    Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current sleep disturbance in older people with a lifetime history of depression is associated with increased connectivity in the Default Mode Network.
    McKinnon AC; Hickie IB; Scott J; Duffy SL; Norrie L; Terpening Z; Grunstein RR; Lagopoulos J; Batchelor J; Lewis SJG; Shine JM; Naismith SL
    J Affect Disord; 2018 Mar; 229():85-94. PubMed ID: 29306697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Application of Automatic Segmentation of Medial Temporal Lobe Subregions in Prodromal and Dementia-Level Alzheimer's Disease.
    Gertje EC; Pluta J; Das S; Mancuso L; Kliot D; Yushkevich P; Wolk D
    J Alzheimers Dis; 2016 Oct; 54(3):1027-1037. PubMed ID: 27567809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
    Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
    Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.
    Scaricamazza E; Colonna I; Sancesario GM; Assogna F; Orfei MD; Franchini F; Sancesario G; Mercuri NB; Liguori C
    Neurol Sci; 2019 Jul; 40(7):1377-1382. PubMed ID: 30903419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment.
    Wearn AR; Nurdal V; Saunders-Jennings E; Knight MJ; Madan CR; Fallon SJ; Isotalus HK; Kauppinen RA; Coulthard EJ
    Neuroimage; 2021 Sep; 238():118214. PubMed ID: 34116150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease.
    Mah L; Binns MA; Steffens DC;
    Am J Geriatr Psychiatry; 2015 May; 23(5):466-76. PubMed ID: 25500120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric symptoms as predictors of conversion from MCI to dementia: a machine learning approach.
    Mallo SC; Valladares-Rodriguez S; Facal D; Lojo-Seoane C; Fernández-Iglesias MJ; Pereiro AX
    Int Psychogeriatr; 2020 Mar; 32(3):381-392. PubMed ID: 31455461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between neuropsychiatric symptoms of affective and vegetative domains and brain morphology in aging people with mild cognitive impairment and Alzheimer's disease.
    Cannizzaro A; Ronat L; El Haffaf LM; Hanganu A;
    Int J Geriatr Psychiatry; 2023 Jun; 38(6):e5952. PubMed ID: 37351584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the Link Between Cardiovascular Risk Factors and Neuropsychiatric Symptoms in Mild Cognitive Impairment and Major Depressive Disorder in Remission.
    Fischer CE; Kortebi I; Karameh WK; Kumar S; Gallagher D; Golas A; Munoz D; Barfett J; Butters MA; Bowie CR; Flint A; Rajji T; Herrmann N; Pollock BG; Mulsant B; Schweizer TA; Mah L;
    J Alzheimers Dis; 2019; 67(4):1305-1311. PubMed ID: 30741676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.
    M FM; Molano A; Castro J; Zarranz JJ
    Curr Alzheimer Res; 2010 Sep; 7(6):517-26. PubMed ID: 20455862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between sleep quality, depressive symptoms and MCI diagnosis: A path analysis.
    McKinnon AC; Beath AP; Naismith SL
    J Affect Disord; 2019 Sep; 256():26-32. PubMed ID: 31158713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of minimal thickness of the medial temporal lobe with hippocampal volume, maximal and minimal hippocampal length: volumetric approach with horizontal magnetic resonance imaging scans for evaluation of a diagnostic marker for neuroimaging of Alzheimer's disease.
    Uotani C; Sugimori K; Kobayashi K
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):319-26. PubMed ID: 16732748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression and Agitation Factors Are Related to Regional Brain Atrophy and Faster Longitudinal Cognitive Decline in Mild Cognitive Impairment.
    Marin-Marin L; Renau-Lagranja J; Ávila C; Costumero V
    J Alzheimers Dis; 2024; 97(3):1341-1351. PubMed ID: 38217601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated segmentation of medial temporal lobe subregions on in vivo T1-weighted MRI in early stages of Alzheimer's disease.
    Xie L; Wisse LEM; Pluta J; de Flores R; Piskin V; Manjón JV; Wang H; Das SR; Ding SL; Wolk DA; Yushkevich PA;
    Hum Brain Mapp; 2019 Aug; 40(12):3431-3451. PubMed ID: 31034738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations Between Hyperactive Neuropsychiatric Symptoms and Brain Morphology in Mild Cognitive Impairment and Alzheimer's Disease.
    El Haffaf LM; Ronat L; Cannizzaro A; Hanganu A;
    J Alzheimers Dis; 2024; 97(2):841-853. PubMed ID: 38143342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medial Temporal Lobe Subregional Atrophy in Aging and Alzheimer's Disease: A Longitudinal Study.
    Chauveau L; Kuhn E; Palix C; Felisatti F; Ourry V; de La Sayette V; Chételat G; de Flores R
    Front Aging Neurosci; 2021; 13():750154. PubMed ID: 34720998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Risk for Alzheimer's Disease Moderates the Association Between Medial Temporal Lobe Volume and Episodic Memory Performance Among Older Adults.
    Prieto S; Valerio KE; Moody JN; Hayes SM; Hayes JP;
    J Alzheimers Dis; 2020; 76(2):591-600. PubMed ID: 32538837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychiatric Symptoms as Risk Factors for Cognitive Decline in Clinically Normal Older Adults: The Cache County Study.
    Burhanullah MH; Tschanz JT; Peters ME; Leoutsakos JM; Matyi J; Lyketsos CG; Nowrangi MA; Rosenberg PB
    Am J Geriatr Psychiatry; 2020 Jan; 28(1):64-71. PubMed ID: 31186157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.